Clinical Trial Update: AlmegaPL CV Health Open Label Study [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial of AlmegaPL for cardiovascular health completed; study focused on cholesterol and triglycerides management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• AlmegaPL

Snippet

Sponsor: Qualitas Health | Conditions: Cholesterol, Triglycerides | Phase 4 | Status: COMPLETED